A detailed history of Man Group PLC transactions in Pfizer Inc stock. As of the latest transaction made, Man Group PLC holds 2,956,275 shares of PFE stock, worth $79.1 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
2,956,275
Previous 1,575,014 87.7%
Holding current value
$79.1 Million
Previous $44.1 Million 94.14%
% of portfolio
0.24%
Previous 0.12%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $38.3 Million - $43.4 Million
1,381,261 Added 87.7%
2,956,275 $85.6 Million
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $35.7 Million - $41.8 Million
-1,413,720 Reduced 47.3%
1,575,014 $44.1 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $58.2 Million - $66.8 Million
2,247,138 Added 303.01%
2,988,734 $82.9 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $3.57 Million - $4.64 Million
-136,704 Reduced 15.56%
741,596 $21.4 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $6.23 Million - $7.28 Million
194,058 Added 28.36%
878,300 $29.1 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $2.58 Million - $2.99 Million
-71,469 Reduced 9.46%
684,242 $25.1 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $41.1 Million - $53.5 Million
-1,043,074 Reduced 57.99%
755,711 $30.8 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $39.3 Million - $51.3 Million
942,135 Added 109.98%
1,798,785 $92.2 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $575,619 - $702,686
13,154 Added 1.56%
856,650 $37.5 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $65.6 Million - $77.8 Million
-1,410,451 Reduced 62.58%
843,496 $44.2 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $76.9 Million - $95.3 Million
1,680,347 Added 292.95%
2,253,947 $117 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $31.2 Million - $46.2 Million
-754,058 Reduced 56.8%
573,600 $33.9 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $43.9 Million - $56.4 Million
-1,118,458 Reduced 45.72%
1,327,658 $57.1 Million
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $48.5 Million - $55 Million
1,351,189 Added 123.4%
2,446,116 $95.8 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $14.7 Million - $16.6 Million
438,789 Added 66.87%
1,094,927 $39.7 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $44.1 Million - $56 Million
-1,316,782 Reduced 66.74%
656,138 $24.2 Million
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $31.9 Million - $37.4 Million
1,005,129 Added 103.86%
1,972,920 $72.4 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $3.59 Million - $4.36 Million
-119,335 Reduced 10.98%
967,791 $31.6 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $18 Million - $25.7 Million
665,415 Added 157.79%
1,087,126 $35.5 Million
Q4 2019

Feb 18, 2020

BUY
$32.92 - $37.36 $4.23 Million - $4.8 Million
128,561 Added 43.86%
421,711 $16.5 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $3.55 Million - $4.61 Million
-109,411 Reduced 27.18%
293,150 $10.5 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $1.56 Million - $1.75 Million
-42,098 Reduced 9.47%
402,561 $17.4 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $6.19 Million - $6.8 Million
-165,047 Reduced 27.07%
444,659 $18.9 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $6.92 Million - $7.89 Million
-179,912 Reduced 22.78%
609,706 $26.6 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $2.37 Million - $2.87 Million
68,637 Added 9.52%
789,618 $34.8 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $3.78 Million - $4.03 Million
-114,574 Reduced 13.71%
720,981 $26.2 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $26.7 Million - $30.9 Million
835,555 New
835,555 $29.7 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.